ScreenerHero

XCX Greenrise Global Brands Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · greenriseglobal.com
0.0050CAD0.00%Mkt Cap: 188093 $P/E: —

Greenrise Global Brands Inc., an investment holding company, focuses on investing in the cannabis industry. The company was formerly known as AMP Alternative Medical Products Inc. and changed its name to Greenrise Global…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap188.09K USD
Enterprise Value2.18M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-528.61K USD
Revenue/Share—
Last Price0.0050 CAD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA39540L1085
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.06
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.00500% of range0.0150
52W High0.0150 CAD
52W Low0.0050 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE26.88%
ROA-776.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-128.27K USD
CapEx (TTM)—
FCF Margin—
FCF Yield81.58%
Net Debt1.99M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.97
Current Ratio0.00
Quick Ratio0.00
Book Value/Sh-0.09 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 3, 2012
Pay Date—
Splits
Last Split3:1
Split DateDec 13, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.51.66M
Float41.66M
Insiders19.94%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short50
Short (prev mo.)832
Technical
SMA 500.0050 (-0.0%)
SMA 2000.0056 (-9.9%)
Beta0.62
S&P 52W Chg16.45%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)37.8
MACD0.0000
MACD Signal-0.0000
MACD Hist.+0.0000
BB Upper0.0050 CAD
BB Middle0.0050 CAD
BB Lower0.0050 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—